Filing Details

Accession Number:
0001104659-18-002870
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-18 16:36:25
Reporting Period:
2018-01-16
Accepted Time:
2018-01-18 16:36:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613859 Pra Health Sciences Inc. PRAH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1181151 Linda Baddour C/O Pra Health Sciences, Inc.
4130 Parklake Avenue, Suite 400
Raleigh NC 27612
Executive Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-16 67,000 $11.73 67,000 No 4 M Direct
Common Stock Disposition 2018-01-16 64,405 $90.26 2,595 No 4 S Direct
Common Stock Disposition 2018-01-16 2,595 $90.56 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-01-16 39,374 $0.00 39,374 $11.73
Common Stock Stock Option (Right to Buy) Disposition 2018-01-16 27,626 $0.00 27,626 $11.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
39,931 2023-12-20 No 4 M Direct
117,669 2023-12-20 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $89.54 to $90.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $90.54 to $90.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  4. The options vested on September 23, 2017.
  5. The options vested on March 2, 2016 upon satisfaction of certain performance criteria.